X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (352) 352
animals (256) 256
male (251) 251
index medicus (243) 243
female (189) 189
cholic acid (181) 181
bile (110) 110
bile acids (110) 110
bile acids and salts - metabolism (110) 110
cholic acids - therapeutic use (104) 104
mice (104) 104
middle aged (97) 97
adult (95) 95
pharmacology & pharmacy (94) 94
rats (92) 92
metabolism (86) 86
gastroenterology & hepatology (83) 83
cholesterol (80) 80
liver (80) 80
acids (76) 76
liver - metabolism (71) 71
deoxycholic acid (69) 69
chenodeoxycholic acid - therapeutic use (67) 67
cholic-acid (67) 67
cholelithiasis - drug therapy (65) 65
aged (60) 60
chenodeoxycholic acid (59) 59
cholic acids - pharmacology (58) 58
ursodeoxycholic acid (57) 57
cholic acids - metabolism (55) 55
rodents (50) 50
ursodeoxycholic acid - therapeutic use (50) 50
biochemistry & molecular biology (48) 48
cholesterol - metabolism (47) 47
bile-acids (46) 46
mice, inbred c57bl (43) 43
medicine (40) 40
liver - drug effects (39) 39
multidisciplinary sciences (39) 39
analysis (36) 36
cholestasis (36) 36
expression (36) 36
lipid metabolism (36) 36
physiological aspects (36) 36
time factors (36) 36
cholesterol - blood (34) 34
metabolites (34) 34
research article (34) 34
bile acids and salts - blood (33) 33
cholic acids (33) 33
cholic acids - blood (33) 33
diet (32) 32
liver - pathology (32) 32
bile - analysis (31) 31
bile acids and salts - therapeutic use (31) 31
cholic acids - administration & dosage (31) 31
lipids (31) 31
absorption (30) 30
kinetics (30) 30
research (30) 30
cholic acid - chemistry (29) 29
disease models, animal (29) 29
liver diseases (29) 29
medicine, research & experimental (29) 29
chemistry, multidisciplinary (28) 28
dose-response relationship, drug (28) 28
in-vitro (28) 28
mass spectrometry (28) 28
chenodeoxycholic acid - metabolism (27) 27
cholagogues and choleretics - therapeutic use (27) 27
gene expression (27) 27
nanoparticles (27) 27
science (27) 27
cholelithiasis - metabolism (26) 26
bile acids and salts - analysis (25) 25
cholic acids - chemistry (25) 25
homeostasis (25) 25
micelles (25) 25
proteins (25) 25
administration, oral (24) 24
adolescent (24) 24
chemistry (24) 24
bile - metabolism (23) 23
bile acid (23) 23
child (23) 23
cholesterol - analysis (23) 23
cholic acid - pharmacology (23) 23
cholic acid - therapeutic use (23) 23
cholic acids - analysis (23) 23
rats, sprague-dawley (23) 23
chenodeoxycholic acid - blood (22) 22
cholic acid - metabolism (22) 22
fxr (22) 22
health aspects (22) 22
intestine (22) 22
microbiota (22) 22
nuclear receptor (22) 22
physiology (22) 22
rats, wistar (22) 22
cancer (21) 21
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (569) 569
German (12) 12
Russian (10) 10
Japanese (6) 6
French (4) 4
Hungarian (3) 3
Chinese (2) 2
Italian (2) 2
Ukrainian (2) 2
Danish (1) 1
Korean (1) 1
Polish (1) 1
Portuguese (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Current medicinal chemistry, ISSN 0929-8673, 2018, Volume 25, Issue 30, pp. 3613 - 3636
Journal Article
Clinics in Liver Disease, ISSN 1089-3261, 05/2016, Volume 20, Issue 2, pp. 365 - 385
Journal Article
Diabetes, obesity & metabolism, ISSN 1462-8902, 2016, Volume 18, Issue 12, pp. 1217 - 1225
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 2016, Volume 11, Issue 1, pp. e0147469 - e0147469
Background Pork is an essential component of the diet that has been linked with major degenerative diseases and development of non-alcoholic steatohepatitis... 
NRF2 | METABOLISM | GLUTATHIONE | MULTIDISCIPLINARY SCIENCES | GENE-EXPRESSION | FUNCTIONAL FOODS | MEAT-PRODUCTS | ATHEROSCLEROSIS | POLYUNSATURATED FATTY-ACIDS | ATHEROGENIC DIET | RICH DIET | Silicon Dioxide - administration & dosage | Cholesterol, Dietary - toxicity | Phenylethyl Alcohol - administration & dosage | Catalase - blood | Rats, Wistar | Cholesterol, Dietary - administration & dosage | Phenylethyl Alcohol - analogs & derivatives | Colloids | Body Weight - drug effects | Non-alcoholic Fatty Liver Disease - etiology | Superoxide Dismutase - blood | Male | Fatty Acids - toxicity | Swine | Dietary Fats - administration & dosage | Aging | Fatty Acids - administration & dosage | Cholic Acid - toxicity | Drug Evaluation, Preclinical | Animal Feed - adverse effects | NF-E2-Related Factor 2 - blood | Silicon Dioxide - pharmacology | Oxidation-Reduction | Liver - metabolism | Rats | Antioxidants - pharmacology | Hypolipidemic Agents - pharmacology | Silicon Dioxide - therapeutic use | Phenylethyl Alcohol - pharmacology | Antioxidants - therapeutic use | Animals | Meat - adverse effects | Antioxidants - administration & dosage | Hypolipidemic Agents - administration & dosage | Non-alcoholic Fatty Liver Disease - prevention & control | Hypolipidemic Agents - therapeutic use | Dietary Fats - toxicity | Phenylethyl Alcohol - therapeutic use | Sus scrofa | Cholic Acid - administration & dosage | Glutathione - blood | Enrichment | Oxidative stress | Hydrogen peroxide | High cholesterol diet | Aluminum | Liver | Lipids | Food science | Cholic acid | Meat | Ingestion | Antioxidants | Counterbalances | Rodents | Atherosclerosis | Oxidation | Silicon | Age | Functional foods & nutraceuticals | Liver diseases | Ingredients | Pharmacology | Metabolism | Gene expression | Fatty acids | Cholesterol | Studies | Nutrition research | Diet | Pharmacy | Laboratory animals | Pork | Index Medicus
Journal Article
BJOG: An International Journal of Obstetrics & Gynaecology, ISSN 1470-0328, 12/2019, Volume 126, Issue 13, pp. 1633 - 1640
Journal Article
Clinics in Liver Disease, ISSN 1089-3261, 08/2018, Volume 22, Issue 3, pp. 501 - 515
.... Ursodeoxycholic acid and obeticholic acid are approved for its treatment. Not all patients respond, some are intolerant, many have ongoing symptoms, and new therapies are required... 
Primary biliary cirrhosis | Unmet need | Novel therapies | Immunomodulators | RHEUMATOID-ARTHRITIS | OBETICHOLIC ACID | LIVER-TRANSPLANTATION | GROWTH-FACTOR 19 | BIOCHEMICAL RESPONSE | BILE-ACID RECEPTOR | URSODEOXYCHOLIC ACID | JANUS KINASE INHIBITOR | PRIMARY BILIARY-CIRRHOSIS | PLACEBO-CONTROLLED TRIAL | GASTROENTEROLOGY & HEPATOLOGY | CD40 Antigens - antagonists & inhibitors | Humans | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal - therapeutic use | Fibroblast Growth Factors - analogs & derivatives | Receptors, G-Protein-Coupled - agonists | Thiazepines - therapeutic use | Fenofibrate - therapeutic use | Pruritus - drug therapy | Chenodeoxycholic Acid - therapeutic use | Pruritus - etiology | Acetates - therapeutic use | Cholic Acids - therapeutic use | Methylamines - therapeutic use | Antirheumatic Agents - therapeutic use | Triazoles - therapeutic use | Peroxisome Proliferator-Activated Receptors - agonists | Bezafibrate - therapeutic use | Liver Cirrhosis, Biliary - drug therapy | Propionates - therapeutic use | Receptors, Cytoplasmic and Nuclear - agonists | Ustekinumab - therapeutic use | Chenodeoxycholic Acid - analogs & derivatives | Janus Kinase Inhibitors - therapeutic use | Abatacept - therapeutic use | PPAR delta - agonists | PPAR gamma - agonists | Chalcones - therapeutic use | PPAR alpha - agonists | Hypolipidemic Agents - therapeutic use | Drug Development | Liver Cirrhosis, Biliary - complications | CD40 Ligand - antagonists & inhibitors | Chemokine CX3CL1 - antagonists & inhibitors
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 2011, Volume 155, Issue 2, pp. 272 - 281
Doxorubicin (DOX) is one of most common anti-cancer chemotherapeutic drugs, but its clinical use is associated with dose-limiting cardiotoxicity... 
Nanotherapeutics | Cancer therapy | Drug delivery | Cardiotoxicity | Doxorubicin | Biodistribution | Polymeric micelles | POLYMERS | PACLITAXEL DELIVERY | EFFICACY | DRUG-DELIVERY | OVARIAN-CANCER | CARRIERS | CHEMISTRY, MULTIDISCIPLINARY | CANCER-THERAPY | NANOPARTICLES | LIPOSOMAL DOXORUBICIN | PHARMACOLOGY & PHARMACY | MULTIDRUG-RESISTANCE | Doxorubicin - therapeutic use | Injections, Intravenous | Cholic Acid - chemistry | Humans | Polyethylene Glycols - chemistry | Doxorubicin - chemistry | Drug Carriers - chemistry | Dose-Response Relationship, Drug | Tissue Distribution | Antibiotics, Antineoplastic - chemistry | Micelles | Female | Antibiotics, Antineoplastic - pharmacokinetics | Doxorubicin - administration & dosage | Lymphoma, B-Cell - drug therapy | Cell Survival - drug effects | Kaplan-Meier Estimate | Solubility | Dendrimers - chemical synthesis | Drug Carriers - chemical synthesis | Doxorubicin - pharmacokinetics | Antibiotics, Antineoplastic - administration & dosage | Particle Size | Xenograft Model Antitumor Assays | Microscopy, Confocal | Animals | Antibiotics, Antineoplastic - therapeutic use | Cell Line, Tumor | Dendrimers - chemistry | Mice | Mice, Inbred BALB C | Microscopy, Fluorescence | Drugs | Anthracyclines | Drug delivery systems | Care and treatment | Analysis | Physiological aspects | Lymphomas | Dosage and administration | Permeability | Vehicles | Cancer | Index Medicus | cancer therapy | biodistribution | cardiotoxicity | polymeric micelles | doxorubicin | drug delivery
Journal Article